Post

Mirum Pharmaceuticals reports positive data from Chenodal trial

US-based biopharmaceutical company Mirum Pharmaceuticals has reported positive findings from the Phase III RESTORE clinical trial of Chenodal (chenodiol) tablets to treat …

Up to 200,000 to be enrolled in UK winter Covid-19 infection study

Up to 200,000 people could take part in the UK's winter Covid-19 infection study (WCIS), to be conducted by the …

Boehringer Ingelheim and CDR-Life to carry out GA drug trial

Boehringer Ingelheim and CDR-Life are set to begin a Phase I clinical trial to analyse the potential of BI 771716 …

Cassava Sciences enrols all patients in Alzheimer’s drug trial

US-based biopharmaceutical company Cassava Sciences has finished enrolling participants in a Phase III clinical trial of an oral drug candidate, simufilam, to …

Acurx Pharmaceuticals concludes Phase IIb trial of CDI therapy

US-based biopharmaceutical company Acurx Pharmaceuticals has completed a Phase IIb clinical trial of its antibiotic candidate ibezapolstat to treat patients with Clostridioides …